May 3, 2021
MindMaze Healthcare, a digital neurotherapeutics company, is expanding its geographical footprint to patients in Latin America, the Middle East, Spain and Switzerland through a series of new partnerships.
The company has inked deals with Peruvian medical biotech company Surgicorp, Saudi Arabian medical company Alkholi, Spanish neurorehabilitation clinic Guttmann Barcelona and Swedish...
November 13, 2018
Switzerland-based MindMaze announced yesterday its acquisition of fellow neuro-rehabilitation tech company Neuro Motor Innovations Corporation (NMI) for an undisclosed sum.
According to the announcement, MindMaze will acquire a perpetual license to NMI’s rehabilitation technology and pick up NMI cofounder Dr. John Krakauer as its now chief medical and chief scientific advisor. Krakauer and...
July 5, 2018
Interest in digital health is now sprouting up all over DC, from the president’s announcement of a new AI task force to FDA Commissioner’s shout out to digital health in his budget request.
In fact, the FDA is turning to developers in the digital health space to help solve some of the country’s most difficult problems. In May, the agency announced an innovation challenge aimed at tackling the...
June 12, 2018
Switzerland-based MindMaze announced today that it has received FDA clearance for the MindMotion Go, a gamified neurorehabilitation therapy platform for medium and light severity impairments able to be deployed in the patient’s home.
Using motion capture technology based on the Microsoft Kinect, the Go engages patients with a range of activities set in displayed 3D environments that promote motor...
June 22, 2017
Virtual reality has moved from science fiction to marketable consumer product astonishingly quickly, partly because the incorporation of the smartphone into the technology makes it accessible, if not ubiquitous. It’s looking more and more like those who bet that virtual reality is here to stay, and not a flash-in-the-pan trend, made the smart bet.
But what about in healthcare? Could a...
May 16, 2017
Swiss neurogaming company MindMaze has received FDA clearance for its MindMotion Pro platform, a motion capture system similar to the Microsoft Kinect which can be used in rehabilitation of stroke and traumatic injury patients.
"In the last few years we’ve launched products at the intersection of the brain and VR," MindMaze CEO Tej Tadi told MobiHealthNews. "What we’ve done today very...
March 17, 2017
The human brain and the seemingly infinite number of health complications that can befall it are complex. As such, there aren’t universally agreed-upon therapies and treatments for conditions ranging from depression and chronic pain to stroke and Parkinson’s disease. But recent, rapid advances in neuroscience research and digital technology are enabling a new wave of tools to gain traction in...
March 3, 2016
So far this year, the digital health funding that MobiHealthNews tracked has surpassed $600 million. In January, digital health companies raised $471 million across 21 deals. This month, funding reached $197 million across 13 deals, although one of those deals was for an undisclosed amount.
More than half of February's funding came from one big deal: MindMaze raised $100 million. An honorary...
February 17, 2016
MindMaze, a Swiss company that uses virtual reality to help stroke victims through their recovery, has raised $100 million in funding to bring its product to the United States. The Hinduja Group, a global conglomerate that has invested since the company's early stages, led the round.
The company's software uses optical motion tracking, similar in form factor to the Microsoft Kinect. For stroke...